RIVASTIGMINE

Course overview

RIVASTIGMINE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF NEURODEGENERATIVE DISEASE, SPECIFICALLY DEMENTIA IN ALZHEIMER PATIENTS AND PARKINSON DISEASE. IT IS IN THE ANTICHOLINERGIC CLASS OF DRUGS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR RIVASTIGMINE AS A VALUABLE AGENT IN MANAGING DEMENTIA (AND OTHER DISORDERS WHEN APPLICABLE). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH DEMENTIA AND RELATED CONDITIONS.